- 4-Week # shares sold: 1,000
- 12-Week # shares sold: 2,000
- 24-Week # shares sold: 4,000
Jim Cramer considers how President Trump might impact stocks in the Action Alerts PLUS charitable trust.
Jim Cramer doesn't like retail and he doesn't like health care stocks. Here's why.
New bowel drug Trulance will be available for patients later this quarter.